DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Ireland" report to their offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
1. HEALTHCARE SYSTEM
Facts & Figures
Provision & Funding
Universal Health Insurance
New Patented Drugs
Admission to Reimbursement
Reference Price Reimbursement System
5. PRICE BUILD UP
6. COST CONTAINMENT
Preferred Drugs List
7. FUTURE DEVELOPMENTS
Reform of State-funded Healthcare Schemes
8. NAMES & ADDRESSES
For more information about this report visit http://www.researchandmarkets.com/research/trhtr7/ims